Marked eosinophilia in an immunosuppressed patient with strongyloidiasis.
Strongyloidiasis in immunocompromised patients is typically associated with a fulminant clinical course and little eosinophilia. We describe an immunocompromised patient with strongyloidiasis in whom the infection was only minimally symptomatic in association with a dramatic increase in eosinophil count.
Savage
D
D
Department of Haematology, Charing Cross Hospital, London, UK.
Foadi
M
M
Haworth
C
C
Grant
A
A
D000328:Adult; D000818:Animals; D001859:Bone Neoplasms / Q000628:therapy; D003131:Combined Modality Therapy / Q000009:adverse effects; D004802:Eosinophilia / Q000469:parasitology*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D009101:Multiple Myeloma / Q000628:therapy; D017171:Strongyloides stercoralis; D013322:Strongyloidiasis / Q000150:complications* / Q000276:immunology